JPWO2022158528A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022158528A5 JPWO2022158528A5 JP2022576742A JP2022576742A JPWO2022158528A5 JP WO2022158528 A5 JPWO2022158528 A5 JP WO2022158528A5 JP 2022576742 A JP2022576742 A JP 2022576742A JP 2022576742 A JP2022576742 A JP 2022576742A JP WO2022158528 A5 JPWO2022158528 A5 JP WO2022158528A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutical composition
- carbon atoms
- composition according
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 125000004432 carbon atom Chemical group C* 0.000 claims 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 8
- 239000003443 antiviral agent Substances 0.000 claims 4
- 125000003277 amino group Chemical group 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 3
- 241001678559 COVID-19 virus Species 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 claims 2
- 241000725619 Dengue virus Species 0.000 claims 2
- 241000710831 Flavivirus Species 0.000 claims 2
- 241000710842 Japanese encephalitis virus Species 0.000 claims 2
- 241000710886 West Nile virus Species 0.000 claims 2
- 241000710772 Yellow fever virus Species 0.000 claims 2
- 241000907316 Zika virus Species 0.000 claims 2
- 229940051021 yellow-fever virus Drugs 0.000 claims 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 1
- 208000025721 COVID-19 Diseases 0.000 claims 1
- 241000711573 Coronaviridae Species 0.000 claims 1
- 108091005804 Peptidases Proteins 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021007531 | 2021-01-20 | ||
| PCT/JP2022/001997 WO2022158528A1 (ja) | 2021-01-20 | 2022-01-20 | 抗ウイルス剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022158528A1 JPWO2022158528A1 (https=) | 2022-07-28 |
| JPWO2022158528A5 true JPWO2022158528A5 (https=) | 2025-01-28 |
Family
ID=82549509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022576742A Pending JPWO2022158528A1 (https=) | 2021-01-20 | 2022-01-20 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240131046A1 (https=) |
| EP (1) | EP4282420A4 (https=) |
| JP (1) | JPWO2022158528A1 (https=) |
| KR (1) | KR20230137361A (https=) |
| CN (1) | CN116761615A (https=) |
| AU (1) | AU2022210132A1 (https=) |
| CA (1) | CA3206486A1 (https=) |
| WO (1) | WO2022158528A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117820248A (zh) * | 2021-04-14 | 2024-04-05 | 盐野义制药株式会社 | 具有病毒增殖抑制作用的三嗪衍生物及含有其的药物组合物 |
| CN116782904A (zh) * | 2021-09-28 | 2023-09-19 | 盐野义制药株式会社 | 含有三嗪衍生物的医药组合物 |
| CA3233206A1 (en) * | 2021-09-28 | 2023-04-06 | Yuki Tachibana | Pharmaceutical composition containing triazine derivative |
| TW202320793A (zh) * | 2021-09-28 | 2023-06-01 | 日商塩野義製藥股份有限公司 | 含有三嗪衍生物之醫藥組合物 |
| JP7253866B1 (ja) * | 2021-11-24 | 2023-04-07 | 塩野義製薬株式会社 | トリアジン誘導体を含有する経口投与する製剤 |
| WO2023054732A2 (ja) * | 2022-01-19 | 2023-04-06 | 塩野義製薬株式会社 | 新型コロナウイルス感染症治療用医薬 |
| WO2024076951A2 (en) * | 2022-10-04 | 2024-04-11 | The Scripps Research Institute | Antiviral prodrugs and formulations thereof |
| JPWO2024075794A1 (https=) * | 2022-10-04 | 2024-04-11 | ||
| CN117357531A (zh) * | 2023-09-08 | 2024-01-09 | 湖北九康通生物医药有限公司 | 一种药物组合物、其制备方法和其应用 |
| CN117417387A (zh) * | 2023-09-13 | 2024-01-19 | 苏州翔实医药发展有限公司 | 一种核苷类似物的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005020885A2 (en) * | 2003-05-21 | 2005-03-10 | Isis Pharmaceuticals, Inc. | Compositions and methods for the treatment of severe acute respiratory syndrome (sars) |
| US11738025B2 (en) * | 2020-02-04 | 2023-08-29 | Oyagen, Inc. | Method for treating coronavirus infections |
| MX2022012360A (es) * | 2020-04-01 | 2022-10-21 | Union Therapeutics As | Tratamiento. |
| KR20210151949A (ko) * | 2020-04-05 | 2021-12-14 | 화이자 인코포레이티드 | Covid-19의 치료를 위한 화합물 및 방법 |
| IL297319A (en) * | 2020-04-13 | 2022-12-01 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Use of metabolic regulators for the treatment of covid-19 |
| EP3930730A4 (en) * | 2020-04-15 | 2022-05-11 | Starpharma Pty Limited | PROPHYLAXIS FOR CORONAVIRUS AND/OR RESPIRATORY SYNCYTIAL VIRUS INFECTION |
| EP3912628A1 (en) * | 2020-05-20 | 2021-11-24 | Institut de Recherche en Semiochimie et Ethologie Appliquée | Nucleoside analogues to inhibit the main protease of a coronavirus |
| US20220177982A1 (en) * | 2020-12-03 | 2022-06-09 | Regeneron Pharmaceuticals, Inc. | Methods Of Identifying Subjects Having An Increased Risk Of Developing A Coronavirus Infection And Treatment Thereof |
-
2022
- 2022-01-20 AU AU2022210132A patent/AU2022210132A1/en not_active Abandoned
- 2022-01-20 EP EP22742650.9A patent/EP4282420A4/en active Pending
- 2022-01-20 US US18/262,326 patent/US20240131046A1/en active Pending
- 2022-01-20 CN CN202280010804.2A patent/CN116761615A/zh active Pending
- 2022-01-20 JP JP2022576742A patent/JPWO2022158528A1/ja active Pending
- 2022-01-20 KR KR1020237027751A patent/KR20230137361A/ko active Pending
- 2022-01-20 WO PCT/JP2022/001997 patent/WO2022158528A1/ja not_active Ceased
- 2022-01-20 CA CA3206486A patent/CA3206486A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2022158528A5 (https=) | ||
| JP2010539241A5 (https=) | ||
| US9676808B2 (en) | 2′,4′-substituted nucleosides as antiviral agents | |
| JP2011521903A5 (https=) | ||
| JP2011518835A5 (https=) | ||
| RU2403258C2 (ru) | Тиазолилдигидроиндазолы | |
| RU2405774C2 (ru) | Гетероциклические ингибиторы аспартилпротеазы | |
| EP1321463B1 (en) | Thiazole derivatives and their use for the treatment or prevention of Flavivirus infections | |
| JP2014514308A5 (https=) | ||
| ME01294B (me) | Nova jedinjenja i kompozicije i metode upotrebe | |
| JP5837936B2 (ja) | アルキルスルフィニル置換チアゾリド化合物 | |
| JP2012517444A5 (https=) | ||
| RU2010112408A (ru) | Фосфадиазиновые ингибиторы iv полимеразы hcv | |
| RU2488582C2 (ru) | Бициклозамещенные азопроизводные пиразолона, способ их получения и фармацевтическое применение | |
| JP2024001048A5 (https=) | ||
| CA2490200A1 (en) | 2' and 3'-nucleoside prodrugs for treating flaviviridae infections | |
| AR036672A1 (es) | Derivados de pirrolidinona | |
| JP2006515858A5 (https=) | ||
| RU2008119842A (ru) | Производные триазола в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы-1 | |
| AR044856A1 (es) | Acidos biariloximetilarenocarboxilicos; procedimientos para su preparacion; composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos. | |
| JPWO2023106310A5 (https=) | ||
| JPWO2022251502A5 (https=) | ||
| JP2021529159A5 (https=) | ||
| JPWO2023095860A5 (https=) | ||
| JP2021510709A5 (https=) |